|
OMIM |
Link |
Information gain |
01 |
|
aspartylglucosaminuria
|
[NCBI]
|
0.000799263
|
|
|
mucopolysaccharidosis type viii
|
[NCBI]
|
0.000308516
|
|
|
TSD
|
[NCBI]
|
0.000182499
|
|
|
RA
|
[NCBI]
|
0.000160718
|
|
|
mucopolysaccharidosis type iiid
|
[NCBI]
|
0.000106987
|
|
|
helicobacter pylori infection, susceptibility to
|
[NCBI]
|
9.36414e-05
|
|
|
sialuria
|
[NCBI]
|
9.20223e-05
|
|
|
blood group, p system
|
[NCBI]
|
8.65092e-05
|
|
|
MBL2
|
[NCBI]
|
8.35121e-05
|
|
|
gaucher disease, type iii
|
[NCBI]
|
8.1107e-05
|
|
|
MSD
|
[NCBI]
|
7.00076e-05
|
|
|
FCN2
|
[NCBI]
|
3.71414e-05
|
|
|
HNRPM
|
[NCBI]
|
3.71414e-05
|
|
|
ST6GALNAC1
|
[NCBI]
|
3.71414e-05
|
|
|
ST6GAL2
|
[NCBI]
|
3.43407e-05
|
|
|
MAN2A2
|
[NCBI]
|
3.43407e-05
|
|
|
nucleoporin, 210-kd
|
[NCBI]
|
3.43407e-05
|
|
|
FCN1
|
[NCBI]
|
3.11706e-05
|
|
|
TRAK1
|
[NCBI]
|
3.00937e-05
|
|
|
MGEA5
|
[NCBI]
|
2.91983e-05
|
|
|
OGT
|
[NCBI]
|
2.8432e-05
|
|
|
CHIT1
|
[NCBI]
|
2.77622e-05
|
|
|
ZP3
|
[NCBI]
|
2.52894e-05
|
|
|
CLEC4M
|
[NCBI]
|
2.52894e-05
|
|
|
CD209
|
[NCBI]
|
2.45519e-05
|
|
|
tay-sachs disease, ab variant
|
[NCBI]
|
2.25648e-05
|
|
|
mucopolysaccharidosis type iva
|
[NCBI]
|
1.94402e-05
|
|
|
HP
|
[NCBI]
|
1.9117e-05
|
|
|
DSPP
|
[NCBI]
|
1.63634e-05
|
|
|
CF
|
[NCBI]
|
1.43167e-05
|
|
|
MAPT
|
[NCBI]
|
1.36192e-05
|
|
|
CEACAM5
|
[NCBI]
|
1.29335e-05
|
|
|
HDC
|
[NCBI]
|
8.36937e-06
|
|
|
GPI
|
[NCBI]
|
8.18784e-06
|
|
|
SRF
|
[NCBI]
|
6.91402e-06
|
|
|
SOD2
|
[NCBI]
|
5.52462e-06
|
|
|
XDH
|
[NCBI]
|
4.12575e-06
|
|
|
CCK
|
[NCBI]
|
2.57522e-06
|
|
|
PTK2
|
[NCBI]
|
2.56925e-06
|
|
|
ACHE
|
[NCBI]
|
1.66844e-06
|
|
|
EGFR
|
[NCBI]
|
1.51941e-06
|
|
|
PRL
|
[NCBI]
|
6.94001e-07
|
|
|
EGF
|
[NCBI]
|
6.30738e-07
|
|
|
PTH
|
[NCBI]
|
5.24419e-07
|
|
|
GFAP
|
[NCBI]
|
5.25921e-08
|
|